Australian Institute for Bioengineering & Nanotechnology
The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) brings together the skills of world-class researchers in the areas of bioengineering and nanotechnology.
As Australia’s first fully integrated research institute, AIBN applies a multidisciplinary approach to understanding and exploiting nanostructures, the genetic basis of cell activity, and opportunities at the interface between bioengineering and nanotechnology.
The Institute comprises 19 research groups working at the interface of the biological, chemical and physical science to alleviate current problems in human health and environmental issues.
AIBN's three key focus areas are: Research excellence; Industry focus; and Dynamic research environment. The Institute draws upon existing research capabilities at UQ in biology, chemistry and engineering with the aim of producing innovative solutions to complex research problems within an environment that transcends traditional borders. Research and development efforts are focused upon the development of new products and devices for improving human health and quality of life.
AIBN is comprised of a dynamic collection of internationally acknowledged chief investigators with proven track records in attracting competitive grant funding and fellowships. This has resulted in a highly-integrated environment with major research in the areas of:
-
Nanotechnology-based imaging and drug delivery for therapeutic products;
-
Regenerative medicine: biology, stem cells and novel scaffolds;
-
Novel protein expression utilising metabolomics and systems biotechnology; and
-
Nanotechnology for energy and environmental applications.
AIBN is also deployed on industry problems through consulting, partnering and contract research.
